849106-18-9 Usage
Uses
Used in Pharmaceutical Industry:
2-(2-bromo-5-chlorophenyl)-4,4-dimethyl-4,5-dihydrooxazole is used as an antifungal agent for its ability to inhibit the synthesis of ergosterol, leading to the disruption of fungal cell walls and the death of the fungus. This makes it effective against a broad spectrum of fungi, including dermatophytes, yeast, and mold.
Used in Treatment of Fungal Infections:
In the medical field, 2-(2-bromo-5-chlorophenyl)-4,4-dimethyl-4,5-dihydrooxazole is used as a therapeutic agent for treating various fungal infections such as athlete's foot, ringworm, and candidiasis due to its wide-ranging activity against different types of fungi.
Used in Veterinary Medicine:
Similarly, in veterinary medicine, 2-(2-bromo-5-chlorophenyl)-4,4-dimethyl-4,5-dihydrooxazole is employed as an antifungal agent to treat fungal infections in animals, ensuring their health and well-being.
Check Digit Verification of cas no
The CAS Registry Mumber 849106-18-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,1,0 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 849106-18:
(8*8)+(7*4)+(6*9)+(5*1)+(4*0)+(3*6)+(2*1)+(1*8)=179
179 % 10 = 9
So 849106-18-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H11BrClNO/c1-11(2)6-15-10(14-11)8-5-7(13)3-4-9(8)12/h3-5H,6H2,1-2H3
849106-18-9Relevant articles and documents
CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
-
Paragraph 1330; 1331, (2016/02/21)
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.
Chemokine receptor antagonists and methods of use thereof
-
, (2008/06/13)
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.
